| Trial ID: | L0263 |
| Source ID: | NCT00194961
|
| Associated Drug: |
Recombinant Human Growth Hormone
|
| Title: |
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Recombinant Human Growth Hormone
|
| Outcome Measures: |
Primary: The primary objective will be to evaluate biochemical/metabolic, and immunologic parameters in relation to body composition., pre- and post-rhGH therapy | Secondary: The secondary objective is to examine the efficacy of rhGH to improve growth velocity in prepubertal, rhGH naïve, children with growth failure secondary to CKD.
|
| Sponsor/Collaborators: |
Sponsor: Weill Medical College of Cornell University | Collaborators: Genentech, Inc.
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-03-25
|
| Locations: |
Weill Medical College of Cornell University, New York, New York, 10021, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00194961
|
